$CTSO News Article - First Patient Enrolled in the PROCYSS Multicenter Randomized Controlled Trial Evaluating CytoSorb to Restore Hemodynamic Stability in Patients with Refractory Septic Shock
https://marketwirenews.com/news-releases/firs...19198.html